Polycystic ovary syndrome (PCOS) is a hormonal condition affecting 10 to 13% of women of reproductive age, driven by a self-reinforcing loop between the brain, ovaries, and metabolism. At its core, PCOS involves excess androgen production (hormones like testosterone), irregular ovulation, and often insulin resistance, all feeding into each other in ways that make the condition persistent and wide-ranging in its effects.
The Hormonal Signal That Starts the Chain
PCOS begins with a signaling problem in the brain. The hypothalamus, which acts as a hormonal control center, sends out pulses of a chemical messenger called GnRH. In women with PCOS, these pulses fire unusually fast. That rapid pulsing causes the pituitary gland to favor production of luteinizing hormone (LH) over follicle-stimulating hormone (FSH). The result is an LH-to-FSH ratio that can climb anywhere from slightly above 1 to as high as 5.5, when it should be closer to equal.
This imbalance matters because LH and FSH have different jobs. FSH is what coaxes a follicle in the ovary to mature into an egg ready for release. LH, on the other hand, stimulates cells in the ovary called theca cells to produce androgens. When LH runs high and FSH stays low, you get a combination of too many androgens and not enough follicle development to complete ovulation.
How the Ovaries Respond
The ovaries in PCOS aren’t damaged. They’re overresponsive to the wrong signal. Theca cells, which form the outer shell of developing follicles, ramp up androgen production in response to elevated LH. At the same time, increased blood vessel growth within the ovarian tissue (driven by vascular growth factors) makes the ovary’s inner structure appear thicker and more vascular on imaging, which further supports androgen output.
Multiple follicles begin developing but stall before any one of them matures enough to release an egg. These stalled follicles, each measuring 2 to 9 mm, accumulate in the ovary. On ultrasound, this looks like a ring of small cysts, which is where the name “polycystic” comes from. Under current diagnostic guidelines, 20 or more of these small follicles in at least one ovary, or an ovarian volume of 10 ml or greater, qualifies as polycystic ovarian morphology. Without a dominant follicle maturing and releasing, ovulation becomes irregular or stops altogether.
Insulin’s Role as an Amplifier
Insulin resistance is not just a side effect of PCOS. It actively drives the condition forward. In many women with PCOS, cells throughout the body respond poorly to insulin, so the pancreas compensates by producing more. That excess circulating insulin does something specific in the ovaries: it acts alongside LH as a co-stimulator of theca cells, amplifying androgen production beyond what LH alone would cause.
High insulin also suppresses the liver’s production of sex hormone binding globulin (SHBG), a protein that normally binds to testosterone and keeps it inactive in the bloodstream. With less SHBG circulating, more testosterone floats free and active, intensifying symptoms like acne, excess hair growth, and hair thinning. Insulin also stimulates the adrenal glands to produce their own androgens, adding yet another source to the surplus. This creates a feedback loop: more insulin leads to more androgens, and the metabolic disruption makes insulin resistance worse over time.
About 30% of women with PCOS meet the criteria for metabolic syndrome, a cluster of conditions including high blood sugar, abnormal cholesterol, and elevated blood pressure that significantly raises the risk of type 2 diabetes and cardiovascular disease.
Why Genetics Load the Gun
PCOS runs strongly in families. Twin studies estimate heritability at 66 to 79%, meaning genetics account for the majority of a person’s susceptibility. Genome-wide studies have identified roughly 30 genetic regions linked to PCOS, and these genes aren’t random. They cluster around the exact pathways involved in the condition: gonadotropin signaling, androgen production, follicle development, and blood sugar regulation.
One gene that comes up repeatedly is DENND1A, which is involved in androgen synthesis within theca cells. Rare variants in this gene were found in half of the PCOS families analyzed in one study. Other implicated genes include those coding for LH and FSH receptors, the insulin receptor, and genes already known to raise the risk of type 2 diabetes. This genetic overlap helps explain why PCOS isn’t purely a reproductive condition but a metabolic one too.
Four Ways PCOS Can Present
Not every woman with PCOS looks the same clinically. Diagnosis requires any two of three features: irregular ovulation, excess androgens (either visible symptoms or elevated blood levels), and polycystic ovaries on ultrasound or elevated anti-Müllerian hormone. The combinations of these three features create four distinct phenotypes:
- Phenotype A: All three features present. This is the most metabolically severe form.
- Phenotype B: Irregular ovulation plus excess androgens, without polycystic ovaries on imaging.
- Phenotype C: Excess androgens plus polycystic ovaries, but with relatively regular cycles.
- Phenotype D: Irregular ovulation plus polycystic ovaries, without obvious androgen excess.
This is why two women with PCOS can have very different experiences. One may struggle primarily with acne and unwanted hair growth while ovulating mostly on schedule. Another may have regular-looking skin but go months without a period. The underlying hormonal mechanics are the same, but the balance of each component varies.
How the Cycle Stays Stuck
What makes PCOS so persistent is that its components reinforce each other. Excess androgens from the ovaries disrupt follicle maturation, preventing ovulation. Without ovulation, the body doesn’t produce progesterone in the second half of the menstrual cycle, which would normally help reset the hormonal environment. The absence of that progesterone signal allows LH pulsing to remain rapid, which keeps androgen production high. Meanwhile, insulin resistance worsens with weight gain (though it also occurs in lean women with PCOS), further amplifying the whole system.
This self-perpetuating loop is why PCOS doesn’t typically resolve on its own without some form of intervention, whether through lifestyle changes that improve insulin sensitivity, medications that lower insulin levels, or hormonal treatments that suppress androgen production or restore regular ovulation.
How Treatments Interrupt the Loop
Most PCOS treatments work by breaking into the cycle at a specific point. Medications that improve insulin sensitivity reduce the amount of insulin circulating in the body, which lowers its co-stimulating effect on theca cells and allows SHBG levels to recover. Studies beginning in the 1990s showed that improving insulin sensitivity in women with PCOS increased the likelihood of ovulation and pregnancy, even without additional fertility drugs.
Hormonal contraceptives take a different approach: they suppress LH secretion from the pituitary, which reduces ovarian androgen production directly. They also raise SHBG levels, further lowering free testosterone. For women not trying to conceive, this addresses both the symptoms (acne, hair growth) and the lack of regular periods, which carries its own health risks since the uterine lining needs to shed periodically.
Lifestyle changes that reduce body fat by even 5 to 10% can meaningfully improve insulin sensitivity, lower androgen levels, and restore ovulation in some women. This isn’t because weight caused the PCOS, but because reducing insulin resistance weakens one of the strongest amplifiers in the loop. Lean women with PCOS benefit from different strategies targeting the hormonal signaling more directly.